Maxim analyst Brian Kinstlinger raised his price target on CACI to $174 after the company's Q2 earnings beat thanks to stronger-than-expected award fees as well as a better performance on fixed price programs. The analyst expects revenue growth to be sustainable, with the company having been awarded about $1.1B in contracts during Q2, while keeping his Buy rating on CACI.

Consensus $20.31. Raises FY24 revenue view to $7.5B-$7.6B from $7.3B-$7.5B, consensus $7.4B.

Reports Q3 revenue $1.94B, consensus $1.86B. "CACI's outstanding performance reflects the continued successful execution of our strategy. We're winning and delivering in the marketplace with differentiated capabilities, exceptional business development, and program execution," said John Mengucci, CEO. "Our third quarter results were strong across the board, including double-digit organic growth, margin expansion, $3.5 billion of awards, and record backlog. Our performance enables us to again raise fiscal year 2024 revenue and earnings guidance. We remain confident in our ability to drive long-term growth, increase free cash flow, and generate value for our customers and our shareholders."